Total Assets Summary of PetMed Express, Inc.

PetMed Express, Inc.'s latest annual total assets in 2024 was 175.09 Million USD , up 3.51% from previous year.
PetMed Express, Inc.'s latest quarterly total assets in 2024 FY was 175.09 Million USD , up 6.69% from previous quarter.
PetMed Express, Inc. reported annual total assets of 164.11 Million USD in 2023, down -6.92% from previous year.
PetMed Express, Inc. reported annual total assets of 176.31 Million USD in 2022, down -5.96% from previous year.
PetMed Express, Inc. reported quarterly total assets of 180.73 Million USD for 2024 Q1, up 10.13% from previous quarter.
PetMed Express, Inc. reported quarterly total assets of 159.27 Million USD for 2024 Q2, down -11.88% from previous quarter.

Annual Total Assets Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Total Assets of PetMed Express, Inc. (2024 - 2000)

Year	Total Assets	Total Assets Growth
2024	175.09 Million USD	3.51%
2023	164.11 Million USD	-6.92%
2022	176.31 Million USD	-5.96%
2021	187.49 Million USD	20.71%
2020	155.32 Million USD	0.58%
2019	154.42 Million USD	14.53%
2018	134.83 Million USD	19.53%
2017	112.8 Million USD	24.96%
2016	90.27 Million USD	8.96%
2015	82.85 Million USD	5.71%
2014	78.37 Million USD	7.1%
2013	73.17 Million USD	-19.64%
2012	91.06 Million USD	-14.32%
2011	106.28 Million USD	2.03%
2010	104.16 Million USD	27.09%
2009	81.96 Million USD	11.58%
2008	73.45 Million USD	19.99%
2007	61.21 Million USD	43.62%
2006	42.62 Million USD	51.58%
2005	28.11 Million USD	52.16%
2004	18.48 Million USD	104.76%
2003	9.02 Million USD	93.93%
2002	4.65 Million USD	3.32%
2001	4.5 Million USD	-28.79%
2000	6.32 Million USD	0.0%

Year	Total Assets	Total Assets Growth
2024 FY	175.09 Million USD	6.69%
2024 Q1	180.73 Million USD	10.13%
2024 Q2	159.27 Million USD	-11.88%
2024 Q3	173.35 Million USD	8.84%
2024 Q4	175.09 Million USD	1.01%
2023 Q1	164.73 Million USD	-6.57%
2023 FY	164.11 Million USD	-6.92%
2023 Q2	169.26 Million USD	2.75%
2023 Q3	165.12 Million USD	-2.45%
2023 Q4	164.11 Million USD	-0.61%
2022 FY	176.31 Million USD	-5.96%
2022 Q3	168.42 Million USD	5.67%
2022 Q4	176.31 Million USD	4.68%
2022 Q1	173.32 Million USD	-7.56%
2022 Q2	159.38 Million USD	-8.04%
2021 Q4	187.49 Million USD	12.02%
2021 Q1	162.75 Million USD	4.78%
2021 FY	187.49 Million USD	20.71%
2021 Q3	167.37 Million USD	5.3%
2021 Q2	158.94 Million USD	-2.34%
2020 Q1	144.83 Million USD	-6.21%
2020 Q3	149.54 Million USD	2.75%
2020 Q4	155.32 Million USD	3.86%
2020 FY	155.32 Million USD	0.58%
2020 Q2	145.53 Million USD	0.48%
2019 Q1	152.66 Million USD	13.22%
2019 Q4	154.42 Million USD	-1.59%
2019 Q3	156.91 Million USD	5.97%
2019 FY	154.42 Million USD	14.53%
2019 Q2	148.07 Million USD	-3.01%
2018 Q1	125.66 Million USD	11.4%
2018 Q2	124.88 Million USD	-0.62%
2018 Q3	135.59 Million USD	8.58%
2018 Q4	134.83 Million USD	-0.56%
2018 FY	134.83 Million USD	19.53%
2017 Q1	99.8 Million USD	10.55%
2017 FY	112.8 Million USD	24.96%
2017 Q4	112.8 Million USD	15.56%
2017 Q3	97.62 Million USD	1.13%
2017 Q2	96.52 Million USD	-3.29%
2016 Q3	88.58 Million USD	0.21%
2016 Q4	90.27 Million USD	1.91%
2016 FY	90.27 Million USD	8.96%
2016 Q2	88.4 Million USD	-5.4%
2016 Q1	93.44 Million USD	12.78%
2015 Q3	79.84 Million USD	0.52%
2015 Q1	86.02 Million USD	9.76%
2015 Q4	82.85 Million USD	3.77%
2015 FY	82.85 Million USD	5.71%
2015 Q2	79.42 Million USD	-7.67%
2014 Q2	77.83 Million USD	-4.41%
2014 FY	78.37 Million USD	7.1%
2014 Q4	78.37 Million USD	4.35%
2014 Q3	75.1 Million USD	-3.5%
2014 Q1	81.42 Million USD	11.27%
2013 Q3	70.73 Million USD	-20.85%
2013 Q4	73.17 Million USD	3.46%
2013 Q2	89.36 Million USD	-5.48%
2013 Q1	94.54 Million USD	3.82%
2013 FY	73.17 Million USD	-19.64%
2012 Q1	99.41 Million USD	-6.46%
2012 Q2	87.97 Million USD	-11.51%
2012 FY	91.06 Million USD	-14.32%
2012 Q4	91.06 Million USD	3.01%
2012 Q3	88.4 Million USD	0.49%
2011 FY	106.28 Million USD	2.03%
2011 Q4	106.28 Million USD	-1.82%
2011 Q3	108.26 Million USD	-0.3%
2011 Q2	108.58 Million USD	-5.7%
2011 Q1	115.15 Million USD	10.55%
2010 Q4	104.17 Million USD	5.91%
2010 Q1	101.12 Million USD	23.38%
2010 Q2	96.6 Million USD	-4.47%
2010 Q3	98.35 Million USD	1.81%
2010 FY	104.16 Million USD	27.09%
2009 Q4	81.96 Million USD	-10.35%
2009 Q3	91.43 Million USD	2.42%
2009 Q2	89.27 Million USD	1.59%
2009 Q1	87.87 Million USD	19.63%
2009 FY	81.96 Million USD	11.58%
2008 Q4	73.45 Million USD	1.01%
2008 Q1	70.03 Million USD	14.41%
2008 Q2	74.53 Million USD	6.41%
2008 Q3	72.72 Million USD	-2.43%
2008 FY	73.45 Million USD	19.99%
2007 Q2	53.5 Million USD	3.47%
2007 FY	61.21 Million USD	43.62%
2007 Q3	54.4 Million USD	1.7%
2007 Q4	61.21 Million USD	12.51%
2007 Q1	51.7 Million USD	21.31%
2006 Q2	37.53 Million USD	7.03%
2006 Q4	42.62 Million USD	2.96%
2006 Q3	41.39 Million USD	10.31%
2006 Q1	35.06 Million USD	24.7%
2006 FY	42.62 Million USD	51.58%
2005 Q1	23.18 Million USD	25.48%
2005 FY	28.11 Million USD	52.16%
2005 Q4	28.11 Million USD	15.77%
2005 Q2	23.74 Million USD	2.38%
2005 Q3	24.28 Million USD	2.31%
2004 FY	18.48 Million USD	104.76%
2004 Q1	12.83 Million USD	42.16%
2004 Q3	16.67 Million USD	8.94%
2004 Q2	15.3 Million USD	19.27%
2004 Q4	18.48 Million USD	10.85%
2003 Q4	9.02 Million USD	-4.62%
2003 FY	9.02 Million USD	93.93%
2003 Q3	9.46 Million USD	21.23%
2003 Q2	7.8 Million USD	21.4%
2003 Q1	6.42 Million USD	38.15%
2002 Q1	2.48 Million USD	-44.74%
2002 Q2	3.65 Million USD	46.73%
2002 Q3	3.64 Million USD	-0.2%
2002 Q4	4.65 Million USD	27.68%
2002 FY	4.65 Million USD	3.32%
2001 Q2	4.33 Million USD	-18.69%
2001 Q1	5.33 Million USD	-15.39%
2001 Q3	4.4 Million USD	1.58%
2001 Q4	4.5 Million USD	2.31%
2001 FY	4.5 Million USD	-28.79%
2000 FY	6.32 Million USD	0.0%
2000 Q4	6.3 Million USD	0.0%

Peer Total Assets Comparison of PetMed Express, Inc.

Name	Total Assets	Total Assets Difference
CannBioRx Life Sciences Corp.	5.25 Million USD	-3229.096%
BIMI International Medical Inc.	35.71 Million USD	-390.258%
China Jo-Jo Drugstores, Inc.	95.05 Million USD	-84.198%
Harrow Health, Inc. 8.625% Senior Notes due 2026	311.75 Million USD	43.836%
Harrow Health, Inc. 11.875% Senior Notes due 2027	312.16 Million USD	43.91%
Leafly Holdings, Inc.	21.83 Million USD	-701.891%
Leafly Holdings, Inc.	21.83 Million USD	-701.891%
LifeMD, Inc.	58.48 Million USD	-199.403%
LifeMD, Inc.	58.48 Million USD	-199.403%
TRxADE HEALTH, Inc.	12.53 Million USD	-1297.065%
Walgreens Boots Alliance, Inc.	81.03 Billion USD	99.784%

Global Stocks Search

PetMed Express, Inc. (PETS)

Total Assets Summary of PetMed Express, Inc.

Annual Total Assets Chart of PetMed Express, Inc. (2024 - 2000)

Historical Annual Total Assets of PetMed Express, Inc. (2024 - 2000)

Peer Total Assets Comparison of PetMed Express, Inc.